Member Info for PL75

Add ‘self’ and you get the same 4 tests. Heard nothing about the other 3 other than Orasure not using saliva any more so it’s still out of date.

Everything Sir Al has said is that the test performs well, in fact exceeds the requirements and the focus was on the manufacturing side. I don’t imagine setting up a new mass manufacturing process in the middle of a pandemic is trivial. As Hants has said we’re still within the expected timelines and I’m sure they’re continuing to work as hard and fast as they can. Just because we’re not getting updates every 5 minutes to keep the nervous nellies calm doesn’t mean steady progress is not being made. Don’t forget, they’re ensuring it’s perfect so that there is absolutely no further risk down the line. At that point, it’s more waiting, but this time for the S&S rapidly followed by billions - not an exaggeration giving the recent temporary contract awards for inferior tests.

My best guess is that we’ll miss the dinghy. Don’t worry though, a much better super yacht will still be sat in the dock. The govt will keep chucking money out there at whatever is available. They’re in the thick of it, we’re heading in to the winter months and there’s a huge xmas sized spike in the r value on the way. They’ve got to use the tests they can lay their hand on right now. Until there’s a saliva at home LFD, moonshot won’t be a viable option. When it turns up, you can easily see that the first initial order could easily be for a £1Bn.

Are you going to change your mind and change it again 3 days later?

Quite right, you need rapid testing. For a vaccine to work it needs to be effective for more than 75% of the population. There’s never been a vaccine that effective for a coronavirus. Let’s imagine by some miracle they develop one that effective. You then need the entire population to queue up to take this barely proven vaccine. If it’s difficult to get people to take a test when they’re healthy, good luck trying to persuade them to risk their future health by taking a vaccine. Chances are there’ll be a vaccine with 50% efficacy and only about 50% of the population willing to risk it, a combined effort of 25%. Nowhere near the number of people to stop the ongoing transmission.

Mass testing is the only way to get the r value down. Then you need regular mass screening of the population for track and trace. If you haven’t watched the Beeb documentary comparing the US with South Korea, it’s worth a watch to see how test, track and trace should be done. South Korea are currently have 2.8 cases per 100,000 compared to 367 here. The peak earlier in the year for them was 6 deaths per day.

After considering the above, remind yourself that Awacta are developing a mass test perfect for the above that can be used in combination with BBIs app for ongoing mass screening.

It’s already happened...

https://www.gov.uk/government/news/covid-19-confirmed-in-pet-cat-in-the-uk

During his campaign he said he wants to increase testing seven fold

https://www.statista.com/statistics/1103046/new-coronavirus-covid19-cases-number-worldwide-by-day/

Absolutely right, there is nowhere near the level of testing globally to make the tiniest bit of difference to the spread. The U.K. has increased its PCR testing, but that makes no difference, it’s too slow and the capacity too small. We’re only now seeing rapid tests starting to come through on to the market and whilst the best will ultimately be the ones in demand, there’s such a desperation that poorer tests will sell. The majority of rapid tests are still swab based and whilst a step in the right direction as the results are obtained quicker, at home saliva tests enabling mass screening and regular testing will be the type of test that start to make a difference. As the effects of mass testing are demonstrated, more countries will become interested in affimers. We’re on the cusp of something ridiculously huge. All we need is one thing.... the test.... come on Sir Al, help this to be a xmas to remember for a positive reason, the xmas we all become gazillionaires

Why not post it instead?

Q11: Please could you give a full update on where the company and CONDOR are at with both the BAMS test and LFD? Timelines thus far have been very woolly and non-specific, which whilst I understand to a degree, is very and increasingly frustrating for investors who were expecting a summer launch. BAMS in particular seems to have dropped off the face of the earth since the July RNS update. Could you also confirm whether Avacta are under NDA from UK government with regard to price sensitive information such as LFT performance data?

Avacta is working with UK government programmes, as well as having now also put in place its own clinical and commercial collaborations, to evaluate and clinically validate the high throughput COVID-19 bead-assisted mass spectrometry (BAMS) laboratory assay developed with Adeptrix for CE marking as a professional use diagnostic test. The Company is aiming to have completed its initial clinical evaluation in the next few weeks and will then update shareholders on the timeline and route to market for the test in as much detail as commercial confidentiality will allow. The Company has also stated that it will provide the next update to the market on the lateral flow test, including a timeline to clinical validation and CE marking, when the first pilot batch goes into production.

Plenty cash available for LFDs.... :-)

Imagine the size of the contract for an at home test that can be rolled out nationally. £1bn+ a month?

Brilliant set up, get your quick test and if you want a confirmation, head out to get a PCR. Best case, you’re sorted in 30 mins, worse case you isolate and find out the next day and then if it’s confirmed, full isolation

I agree Doh, it’s groundhog, day, week, month on here...

Meanwhile, no mention of a top up from RK, that was a bearish post.

They’ll bypass usual procurement rules by obtaining dispensation to utilise the mates rates protocol used so successfully in the past. Basically they’ll buy what they need when they need it.

Another swab based test

What is weird is saying you’re selling one day, saying you’re not the next and then a matter of days later saying you’re selling again. It’s like you think anyone gives a sh.t

I agree Oke, the price will in line with Sir Al’s previous comments, they’re in demand, basic economics suggests we won’t give them away.

Sigh

It’s a possibility and was my thought process in posting, time will tell

Beckman Coulter are listed

https://ted.europa.eu/udl?uri=TED:NOTICE:523069-2020:TEXT:EN:HTML&src=0

It’s intrinsically linked, he’s desperate to end furlough but can’t whilst there is the prospect of lockdowns. Mass testing is the route out of lockdown and therefore furlough. Furlough ends when the economy is back, the economy comes back thanks to mass testing.